Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice (in Eng)
Contact us today for a consultation
Patients must be clearly informed of the risks associated with nonFDA-approved products, including potential contamination, inaccurate dosing, variable bioactivity, and the presence of impurities that may provoke adverse or unpredictable effects
Article Google Scholar Agrawal, A
The FDA started cracking down on peptides in 2024 and 2025, sending warning letters to dozens of clinics, pharmacies, and websiteseven the ones saying "research only." The heat is only rising
As dental professionals, physicians, and wellness practitioners expand their scope into integrative health, understanding the science behind peptides can help us better educate patients and make informed decisions about adjunctive therapies